Press enter to begin your search

Poolbeg Pharma - Update

POLB
Thu, 18 Nov 2021, 17:11 GMT

Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company with a capital light clinical model, is pleased to provide an update on the clinical development progress of its lead asset, POLB 001, a small molecule immunomodulator for the treatment of severe influenza.

Cathal Friel
Chairman
POLB
Jeremy Skillington
Chief Executive Officer
POLB
61953f46bfda32066a174ace
SHOW MORE
FROM THIS COMPANY
Poolbeg Pharma - Update
POLB Thu, 18 Nov 2021, 17:11 GMT

Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model.

Industry: Health Care

Contact: +44 207 183 1499
New Road
https://www.poolbegpharma.com/

Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company with a capital light clinical model, is pleased to provide an update on the clinical development progress of its lead asset, POLB 001, a small molecule immunomodulator for the treatment of severe influenza.

Cathal Friel
Chairman
Jeremy Skillington
Chief Executive Officer
POWERED BY